NCT07441993 2026-03-02
MZL-IIT-O
Institute of Hematology & Blood Diseases Hospital, China
Phase 2 Recruiting
Clinical Trials
3 trialsNCT07206264 2025-10-03
ADAPT-MCL
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Not yet recruiting
NCT06015464 2023-08-29
An Ambispective Cohort Study of Orelabrutinib in Combination With Standard Treatment Regimen for Untreated DLBCL
The First Affiliated Hospital with Nanjing Medical University
Unknown